[1]
“Assessment of comorbities in hypertension patients”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 11, no. 1, pp. 12–15, Jan. 2022, doi: 10.61096/ijrpp.v11.iss1.2022.12-15.